Related Experiment Video
Updated: Jun 23, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Hypersensitivity to BKCa channel opening in persistent post-traumatic headache
Haidar M Al-Khazali1,2,3,4,5, Rune H Christensen3,4,5, David W Dodick4,6
1Harvard Medical School, Boston, MA, USA.
Large conductance calcium-activated potassium (BKCa) channel opening with MaxiPost induced migraine-like headaches in persistent post-traumatic headache patients. This suggests BKCa channels are a potential target for new PPTH treatments.
Area of Science:
- Neuroscience
- Pharmacology
- Neurology
Background:
- Large conductance calcium-activated potassium (BKCa) channels are implicated in migraine pathophysiology.
- Persistent post-traumatic headache (PPTH) shares clinical similarities with migraine.
- Investigating BKCa channel activity in PPTH may reveal therapeutic targets.
Purpose of the Study:
- To determine if MaxiPost, a BKCa channel opener, can induce migraine-like headaches in individuals with PPTH.
- To compare the headache-inducing effects of MaxiPost versus placebo in PPTH patients.
Main Methods:
- A randomized, double-blind, placebo-controlled, crossover study was conducted.
- Participants with PPTH and no prior migraine history received intravenous MaxiPost or placebo.
- Headache induction and intensity were assessed over a 12-hour period post-infusion.
Main Results:
- 52% of participants developed migraine-like headaches after MaxiPost, compared to 19% after placebo (P = .02).
- Headache intensity, measured by AUC, was significantly higher with MaxiPost than placebo (P < .001).
Conclusions:
- BKCa channel opening can trigger migraine-like headaches in individuals with PPTH.
- Pharmacological blockade of BKCa channels represents a potential novel therapeutic strategy for PPTH.
- Further research is warranted to confirm these findings and explore BKCa channel blockers for PPTH management.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Mechanically-gated Ion Channels
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Depolarizing Blockers: Pharmocokinetics
Antihypertensive Drugs: Action of Calcium Channel Blockers

